Indonesia vs Syria: Laboratories providing drug susceptibility testing (DST)
Indonesia
0.3
in 2014
Syria
0.3
in 2014
Indonesia rank
109th
Syria rank
109th
Laboratories providing drug susceptibility testing (DST) over time
- Indonesia
- Syria
How they compare
Indonesia currently reports 0.3 against 0.3 in Syria, a difference of 0.
The two have swapped places 3 times across 10 shared years of data; in 2005 it was Indonesia ahead.
Indonesia ranks 109th and Syria ranks 109th of 157 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and Syria in 1.
Head to head by decade
| Decade | Indonesia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.28 | 0.26 | 0.02 | Indonesia |
| 2010s | 0.16 | 0.26 | 0.1 | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher laboratories providing drug susceptibility testing (dst), Indonesia or Syria?
- Indonesia, at 0.3 against 0.3 in Syria as of 2014.
- What is the difference in laboratories providing drug susceptibility testing (dst) between Indonesia and Syria?
- 0, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Syria?
- 10 years are reported by both, from 2005 to 2014.
- How do Indonesia and Syria rank globally for laboratories providing drug susceptibility testing (dst)?
- Indonesia ranks 109th and Syria ranks 109th of 157 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Laboratories providing drug susceptibility testing (DST) (per 5 million population). Statizoid refreshes it automatically from the source and publishes the full history for both places.